EA or Na2EA treatment significantly reduced the number of MV4-11 cells in AML ASID mice, whereas the proportion of CD33 + and CD45 + cells was less than 1% (Figures S10C and S10D, respectively). This evidence concerns the gene PTPRC and acute myeloid leukemia.